Breaking News Instant updates and real-time market news.

VIVE

Viveve

$0.59

-0.0199 (-3.26%)

04:55
04/17/19
04/17
04:55
04/17/19
04:55

Viveve management to meet with -Mizuho

Meetings to be held in West Coast on April 16-17 hosted by Mizuho.

  • 17

    Apr

VIVE Viveve
$0.59

-0.0199 (-3.26%)

07/30/18
CHLM
07/30/18
NO CHANGE
CHLM
Hold
FDA warning to off-label competitors positive for Viveve, says Craig-Hallum
Craig-Hallum analyst Matt Hewitt noted that the FDA published seven "Letters to Industry" that were sent to companies that may be violating the law for inappropriately marketing their energy-based devices for vaginal "rejuvenation," but noted that Viveve (VIVE) was not amongst them. He views this as a positive for Viveve, as it signals that the FDA is cracking down on the off-label promotion that he thinks has been a key commercial challenge for the company. Viveve is the only one in the space currently performing a trial for sexual function, placing it "miles ahead of the competition" in terms of obtaining an actual label, added Hewitt, who keeps a Hold rating on the stock due to concerns over the company's operating cash flow burn and uncertainty about financials. The Fly notes that Cynosure, a unit of Hologic (HOLX), was among the companies to receive an FDA warning.
07/31/18
MZHO
07/31/18
NO CHANGE
Target $4
MZHO
Buy
Seven Viveve competitors get FDA warning letters, says Mizuho
The FDA issued a warning letter to seven competitors of Viveve Medical related to the inappropriate marketing of energy-based devices for the treatment of vaginal rejuvenation, Mizuho analyst Difei Yang tells investors in a research note. The analyst anticipates the competitors will likely stop marketing their devices "off label" in the near term. Since Viveve has not received a letter, Yang sees the development as a positive for the company. The letters to competitors will likely provide an opportunity to compete on equal footing with more established players, especially considering Viveve has received two investigational device exemptions from the FDA to conduct clinical trials in both sexual function and stress urinary incontinence, Yang tells investors in a research note. She reiterates a Buy rating on Viveve shares with a $4 price target.
12/07/18
LTCO
12/07/18
NO CHANGE
Target $8.5
LTCO
Buy
Viveve data supports ongoing clinical activity in SUI, says Ladenburg
After Viveve announced 12-month data from its stress urinary incontinence, or SUI, study, Ladenburg analyst Jeffrey Cohen said he believe this data supports ongoing clinical activity and provides additional support for the LIBERATE International and LIBERATE U.S. studies. He reiterates his Buy rating and $8.50 price target on Viveve shares.
01/02/19
STFL
01/02/19
NO CHANGE
Target $19
STFL
Buy
Sientra added to Select List, IntriCon removed at Stifel
Stifel analyst Jonathan Block added Sientra (SIEN) to the firm's Select List, replacing IntriCon (IIN). His survey of 70 dermatologists, 48 plastic surgeons and 25 other doctors "paints a bullish picture" for adoption of Sientra's miraDry over the next 12-24 months, Block tells investors. The overall shift to non-invasive procedures is expected to continue and it appears that miraDry will play a central role, Block added. He keeps a Buy rating on Sientra shares, though he lowered his price target on the stock to $19 from $24. He also cut his price target on Cutera (CUTR) to $17 from $29 and lowered his price target on Viveve (VIVE) to $3 from $5 following his survey work. Block keeps a Hold rating on Cutera and Buy rating on Viveve.

TODAY'S FREE FLY STORIES

MSFT

Microsoft

$129.78

4.78 (3.82%)

, FB

Facebook

$195.10

12.46 (6.82%)

12:23
04/25/19
04/25
12:23
04/25/19
12:23
On The Fly
Fly Intel: Wall Street's top stories at midday »

The major averages have…

MSFT

Microsoft

$129.78

4.78 (3.82%)

FB

Facebook

$195.10

12.46 (6.82%)

MMM

3M

$195.58

-23.66 (-10.79%)

UPS

UPS

$106.70

-7.69 (-6.72%)

DB

Deutsche Bank

$8.41

-0.09 (-1.06%)

CRZBY

Commerzbank

$0.00

(0.00%)

WMT

Walmart

$103.64

0.13 (0.13%)

FBHS

Fortune Brands

$52.61

2.72 (5.45%)

NOW

ServiceNow

$261.35

18.94 (7.81%)

PYPL

PayPal

$109.86

2.68 (2.50%)

MMLP

Martin Midstream Partners

$7.43

-2.41 (-24.50%)

CNSL

Consolidated Communications

$5.99

-2.9 (-32.62%)

FCX

Freeport McMoRan

$12.68

-0.89 (-6.56%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 26

    Apr

  • 28

    Apr

  • 29

    Apr

  • 29

    Apr

  • 01

    May

  • 05

    May

  • 06

    May

  • 07

    May

  • 09

    May

  • 09

    May

  • 14

    May

  • 14

    May

  • 16

    May

  • 18

    May

  • 21

    May

  • 22

    May

  • 29

    May

  • 30

    May

  • 03

    Jun

  • 03

    Jun

  • 05

    Jun

  • 05

    Jun

  • 07

    Jun

  • 08

    Jun

  • 10

    Jun

  • 11

    Jun

  • 23

    Jun

  • 06

    Aug

  • 13

    Nov

XLF

Financial Select Sector

$27.49

0.1 (0.37%)

12:20
04/25/19
04/25
12:20
04/25/19
12:20
Options
50K SPDR Financials Jun 28 calls trade 30c »

50K SPDR Financials Jun…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MMM

3M

$195.01

-24.23 (-11.05%)

12:18
04/25/19
04/25
12:18
04/25/19
12:18
Hot Stocks
JPMorgan's Tusa says 'no way' 3M can be broken up »

JPMorgan analyst Stephen…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 14

    May

  • 18

    May

  • 29

    May

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

12:17
04/25/19
04/25
12:17
04/25/19
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MMM

3M

$195.20

-24.04 (-10.97%)

12:16
04/25/19
04/25
12:16
04/25/19
12:16
Hot Stocks
JPMorgan's Tusa stands by $154 price target on 3M »

JPMorgan analyst Stephen…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 14

    May

  • 18

    May

  • 29

    May

$NYE

NYSE Market Internals

$0.00

(0.00%)

12:16
04/25/19
04/25
12:16
04/25/19
12:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MMM

3M

$195.55

-23.69 (-10.81%)

, HON

Honeywell

$170.63

-0.63 (-0.37%)

12:15
04/25/19
04/25
12:15
04/25/19
12:15
Hot Stocks
JPMorgan's Tusa says 3M should trade at discount to Honeywell »

JPMorgan analyst Stephen…

MMM

3M

$195.55

-23.69 (-10.81%)

HON

Honeywell

$170.63

-0.63 (-0.37%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 29

    Apr

  • 14

    May

  • 14

    May

  • 18

    May

  • 29

    May

MMM

3M

$195.61

-23.63 (-10.78%)

12:14
04/25/19
04/25
12:14
04/25/19
12:14
Hot Stocks
JPMorgan's Tusa says 3M neither 'growthy' nor 'defensive' »

JPMorgan analyst Stephen…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 14

    May

  • 18

    May

  • 29

    May

MAS

Masco

$38.51

-1.47 (-3.68%)

12:10
04/25/19
04/25
12:10
04/25/19
12:10
Options
3K Masco May 37 - 39 put spreads sold at 83c »

3K Masco May 37 - 39 put…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 10

    May

NITE

Nightstar Therapeutics

$25.54

0.01 (0.04%)

, BIIB

Biogen

$230.56

6.24 (2.78%)

12:07
04/25/19
04/25
12:07
04/25/19
12:07
Hot Stocks
Polygon discloses 7.97% stake in Nightstar, sends letters to board »

Polygon Global Partners…

NITE

Nightstar Therapeutics

$25.54

0.01 (0.04%)

BIIB

Biogen

$230.56

6.24 (2.78%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Apr

  • 01

    May

  • 04

    May

  • 29

    May

FNB

F.N.B.

$11.99

0.01 (0.08%)

12:04
04/25/19
04/25
12:04
04/25/19
12:04
Hot Stocks
First National Bank appoints Samuel Kirsch as chief digitial officer »

First National Bank…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    May

CRC

California Resources

$22.75

-3.55 (-13.50%)

12:00
04/25/19
04/25
12:00
04/25/19
12:00
Hot Stocks
California Resources falls -13.4% »

California Resources is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

  • 08

    May

HZO

MarineMax

$16.59

-3.255 (-16.41%)

12:00
04/25/19
04/25
12:00
04/25/19
12:00
Hot Stocks
MarineMax falls -16.3% »

MarineMax is down -16.3%,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

CLS

Celestica

$7.19

-1.42 (-16.50%)

12:00
04/25/19
04/25
12:00
04/25/19
12:00
Hot Stocks
Celestica falls -16.7% »

Celestica is down -16.7%,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

AAN

Aaron's

$58.07

4.745 (8.90%)

12:00
04/25/19
04/25
12:00
04/25/19
12:00
Hot Stocks
Aaron's rises 9.0% »

Aaron's is up 9.0%,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 08

    May

  • 13

    Nov

WAB

Wabtec

$71.90

-4.67 (-6.10%)

12:00
04/25/19
04/25
12:00
04/25/19
12:00
Options
Downside put buy in Wabtec as shares wobble after earnings »

Downside put buy in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 08

    May

  • 21

    May

  • 05

    Jun

  • 13

    Nov

OIS

Oil States

$20.53

2.11 (11.45%)

12:00
04/25/19
04/25
12:00
04/25/19
12:00
Hot Stocks
Oil States rises 12.4% »

Oil States is up 12.4%,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 07

    May

ASPN

Aspen Aerogels

$3.56

0.36 (11.25%)

12:00
04/25/19
04/25
12:00
04/25/19
12:00
Hot Stocks
Aspen Aerogels rises 12.7% »

Aspen Aerogels is up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

  • 28

    May

NWL

Newell Brands

$13.84

-0.4 (-2.81%)

11:55
04/25/19
04/25
11:55
04/25/19
11:55
Options
Newell Brands put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    May

  • 07

    May

  • 14

    May

  • 15

    May

  • 16

    May

  • 17

    May

11:50
04/25/19
04/25
11:50
04/25/19
11:50
General news
U.S. Treasury tax receipts continue to surge »

U.S. Treasury tax…

GILD

Gilead

$63.57

0.75 (1.19%)

11:48
04/25/19
04/25
11:48
04/25/19
11:48
Recommendations
Gilead analyst commentary at Piper Jaffray »

Piper Jaffray 'not…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

  • 02

    May

  • 03

    May

  • 06

    May

  • 08

    May

  • 18

    May

IMMR

Immersion

$9.27

0.03 (0.32%)

11:45
04/25/19
04/25
11:45
04/25/19
11:45
Options
Immersion call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:45
04/25/19
04/25
11:45
04/25/19
11:45
General news
Treasury's $85 B 4- and 8-week bill auctions were mixed »

Treasury's $85 B 4-…

11:43
04/25/19
04/25
11:43
04/25/19
11:43
General news
8-Week Bill Auction Total Amount data reported »

8-Week Bill Auction Total…

11:43
04/25/19
04/25
11:43
04/25/19
11:43
General news
4-Week Bill Auction Total Amount data reported »

4-Week Bill Auction Total…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.